手法を比較
選択した手法を並べて確認できます。異なる行はハイライト表示されます。
| 小児用DLQI (cDLQI)× | SCORAD指数（アトピー性皮膚炎スコアリング）× | |
|---|---|---|
| 分野 | 皮膚科学 | 皮膚科学 |
| 系統 | Process / pipeline | Process / pipeline |
| 提唱年≠ | 1995 | 1993 |
| 提唱者≠ | Lewis-Jones MS, Finlay AY | European Task Force on Atopic Dermatitis (ETFAD) |
| 種類≠ | Self-report (parent or child proxy) | Clinician-rated |
| 原典≠ | Lewis-Jones MS, Finlay AY. The Children's Dermatology Life Quality Index (cDLQI): initial validation and practical use. Br J Dermatol. 1995;132(6):942-949. DOI ↗ | Kunz B, Oranje AP, Labrèze L, et al. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997;195(1):10-19. DOI ↗ |
| 別名≠ | cDLQI, Pediatric DLQI | SCORAD Index |
| 関連 | 3 | 3 |
| 概要≠ | The Children's Dermatology Life Quality Index (cDLQI) is a pediatric-adapted version of the adult DLQI, measuring the impact of skin disease on quality of life in children and adolescents aged 4–16 years. Developed by Lewis-Jones and Finlay in 1995, it uses child-friendly language and addresses domains relevant to childhood (school, leisure, friendships, clothing) rather than work and adult relationships. cDLQI is the standard quality-of-life measure in pediatric dermatology trials and clinical practice. | The SCORAD is a comprehensive clinician-administered tool for measuring the extent and severity of atopic dermatitis (eczema). Developed by the European Task Force on Atopic Dermatitis in 1993, it combines objective clinical assessment with subjective symptom reporting. It is the gold standard for atopic dermatitis severity in clinical trials and dermatology practice. |
| ScholarGateデータセット ↗ |
|
|